3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
5
Hepatoblastoma
3
Drug-Related Side Effects and Adverse Reactions
3
Central Nervous System Neoplasms
3
Ototoxicity
2
Oligodendroglioma
2
Neoplasms, Germ Cell and Embryonal
2
Medulloblastoma
2
Glioma
2
Gastrointestinal Neoplasms
2
Astrocytoma
2
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Seminoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Optic Nerve Glioma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Mouth Neoplasms
1
Mesothelioma
1
Lymphoma
1
Liver Neoplasms
1
Liposarcoma
1
Interventions
Radiotherapy
4
Surveys and Questionnaires
3
Specimen Handling
2
Iohexol
2
spartalizumab
1
sodium thiosulfate
1
X-Rays
1
Watchful Waiting
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Immunotherapy, Adoptive
1
Hyperthermic Intraperitoneal Chemotherapy
1
FS 069
1
Exercise Test
1
Embolization, Therapeutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pelvic Neoplasms
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled